<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>PILMAN &#187; shift</title>
	<atom:link href="http://www.tapanray.in/tag/shift/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.tapanray.in</link>
	<description>A Tapan Ray Website</description>
	<lastBuildDate>Sun, 22 Mar 2026 10:59:18 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.4.2</generator>
		<item>
		<title>Why And How To Be In-Sync With Gen Z As Pharma Paradigm Shifts?</title>
		<link>http://www.tapanray.in/why-and-how-to-be-in-sync-with-gen-z-as-pharma-paradigm-shifts/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=why-and-how-to-be-in-sync-with-gen-z-as-pharma-paradigm-shifts</link>
		<comments>http://www.tapanray.in/why-and-how-to-be-in-sync-with-gen-z-as-pharma-paradigm-shifts/#comments</comments>
		<pubDate>Mon, 21 Feb 2022 00:00:26 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[Business]]></category>
		<category><![CDATA[care]]></category>
		<category><![CDATA[characteristics]]></category>
		<category><![CDATA[conscious]]></category>
		<category><![CDATA[consumers]]></category>
		<category><![CDATA[core]]></category>
		<category><![CDATA[COVID-19]]></category>
		<category><![CDATA[digital]]></category>
		<category><![CDATA[doctor]]></category>
		<category><![CDATA[expectations]]></category>
		<category><![CDATA[experience]]></category>
		<category><![CDATA[financial]]></category>
		<category><![CDATA[Gen Z]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[Metamorphosis]]></category>
		<category><![CDATA[Millenials]]></category>
		<category><![CDATA[minded]]></category>
		<category><![CDATA[natives]]></category>
		<category><![CDATA[pandemic]]></category>
		<category><![CDATA[paradigm]]></category>
		<category><![CDATA[perspective]]></category>
		<category><![CDATA[Physician]]></category>
		<category><![CDATA[population]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[shift]]></category>
		<category><![CDATA[Survey]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[technology]]></category>
		<category><![CDATA[transformation]]></category>
		<category><![CDATA[value]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=10656</guid>
		<description><![CDATA[As science and technology, across the world, are progressing at a scorching pace &#8211; Covid-19 pandemic notwithstanding, today’s generations are growing up tech savvy &#8211; more than ever before. The trend will keep going north faster and with a steeper &#8230; <a href="http://www.tapanray.in/why-and-how-to-be-in-sync-with-gen-z-as-pharma-paradigm-shifts/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/why-and-how-to-be-in-sync-with-gen-z-as-pharma-paradigm-shifts/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Shift from Disease Centered Care To Patient-Goals Directed Care In The New Normal</title>
		<link>http://www.tapanray.in/shift-from-disease-centered-care-to-patient-goals-directed-care-in-the-new-normal/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=shift-from-disease-centered-care-to-patient-goals-directed-care-in-the-new-normal</link>
		<comments>http://www.tapanray.in/shift-from-disease-centered-care-to-patient-goals-directed-care-in-the-new-normal/#comments</comments>
		<pubDate>Sun, 09 Aug 2020 23:50:04 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[Business]]></category>
		<category><![CDATA[care]]></category>
		<category><![CDATA[cases]]></category>
		<category><![CDATA[centered]]></category>
		<category><![CDATA[centricity]]></category>
		<category><![CDATA[Coronavirus]]></category>
		<category><![CDATA[COVID-19]]></category>
		<category><![CDATA[directed]]></category>
		<category><![CDATA[disease]]></category>
		<category><![CDATA[doctors]]></category>
		<category><![CDATA[focus]]></category>
		<category><![CDATA[goal]]></category>
		<category><![CDATA[GPs]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[New]]></category>
		<category><![CDATA[normal]]></category>
		<category><![CDATA[Old]]></category>
		<category><![CDATA[Patient]]></category>
		<category><![CDATA[Patients]]></category>
		<category><![CDATA[physicians]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[shift]]></category>
		<category><![CDATA[specialists]]></category>
		<category><![CDATA[story]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[treatment]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=10218</guid>
		<description><![CDATA[In the initial days of the first quarter of 2020, no one could fathom that just within the next 4 months over two million fellow citizens will get infected by an unknown virus, recording over 45,500 deaths. Many authorities may &#8230; <a href="http://www.tapanray.in/shift-from-disease-centered-care-to-patient-goals-directed-care-in-the-new-normal/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/shift-from-disease-centered-care-to-patient-goals-directed-care-in-the-new-normal/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>On The Flip Side of Pharma Industry: A Saga of Perennial Contradictions</title>
		<link>http://www.tapanray.in/on-the-flip-side-of-pharma-industry-a-saga-of-perennial-contradictions/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=on-the-flip-side-of-pharma-industry-a-saga-of-perennial-contradictions</link>
		<comments>http://www.tapanray.in/on-the-flip-side-of-pharma-industry-a-saga-of-perennial-contradictions/#comments</comments>
		<pubDate>Mon, 09 Dec 2019 00:00:48 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[CEOs]]></category>
		<category><![CDATA[contradiction]]></category>
		<category><![CDATA[contradictions]]></category>
		<category><![CDATA[Cost]]></category>
		<category><![CDATA[diseases]]></category>
		<category><![CDATA[Drug]]></category>
		<category><![CDATA[expenditure]]></category>
		<category><![CDATA[facet]]></category>
		<category><![CDATA[flip]]></category>
		<category><![CDATA[focus]]></category>
		<category><![CDATA[gene]]></category>
		<category><![CDATA[IMPACT]]></category>
		<category><![CDATA[implementation]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[industry]]></category>
		<category><![CDATA[investment]]></category>
		<category><![CDATA[perennial]]></category>
		<category><![CDATA[prices]]></category>
		<category><![CDATA[primary]]></category>
		<category><![CDATA[R&D]]></category>
		<category><![CDATA[rare]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Saga]]></category>
		<category><![CDATA[Senate]]></category>
		<category><![CDATA[shift]]></category>
		<category><![CDATA[side]]></category>
		<category><![CDATA[strategies]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[therapy]]></category>
		<category><![CDATA[US]]></category>
		<category><![CDATA[vice versa]]></category>
		<category><![CDATA[Voluntary]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=9804</guid>
		<description><![CDATA[Awesome contribution in the battle against multiple diseases, is obviously the primary facet of the pharma industry. However, on its flip side, one would witness a saga of numerous contradictions. Some of these exist perennially in well-protected opaque cocoons, regardless &#8230; <a href="http://www.tapanray.in/on-the-flip-side-of-pharma-industry-a-saga-of-perennial-contradictions/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/on-the-flip-side-of-pharma-industry-a-saga-of-perennial-contradictions/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Pharma Marketing: Time For A Disruptive Change with A New Breed of Marketers</title>
		<link>http://www.tapanray.in/pharma-marketing-time-for-a-disruptive-change-with-a-new-breed-of-marketers/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=pharma-marketing-time-for-a-disruptive-change-with-a-new-breed-of-marketers</link>
		<comments>http://www.tapanray.in/pharma-marketing-time-for-a-disruptive-change-with-a-new-breed-of-marketers/#comments</comments>
		<pubDate>Mon, 11 Mar 2019 00:00:51 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[brand]]></category>
		<category><![CDATA[breed]]></category>
		<category><![CDATA[care]]></category>
		<category><![CDATA[Change]]></category>
		<category><![CDATA[demands]]></category>
		<category><![CDATA[Disruptive]]></category>
		<category><![CDATA[Drug]]></category>
		<category><![CDATA[environmental]]></category>
		<category><![CDATA[focus]]></category>
		<category><![CDATA[fundamental]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[marketer]]></category>
		<category><![CDATA[marketing]]></category>
		<category><![CDATA[New]]></category>
		<category><![CDATA[persona]]></category>
		<category><![CDATA[personality]]></category>
		<category><![CDATA[Product]]></category>
		<category><![CDATA[pull]]></category>
		<category><![CDATA[Push]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[role]]></category>
		<category><![CDATA[services]]></category>
		<category><![CDATA[shift]]></category>
		<category><![CDATA[success]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=9440</guid>
		<description><![CDATA[In Today’s fast-changing world, as I indicated in several of my previous articles, more and more people first try to understand the causative factors of their ailments, and options available for effective remedial measures. They strive to get such information, &#8230; <a href="http://www.tapanray.in/pharma-marketing-time-for-a-disruptive-change-with-a-new-breed-of-marketers/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/pharma-marketing-time-for-a-disruptive-change-with-a-new-breed-of-marketers/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Does ‘Patient-Centricity’ Now Sound Like A Cliché?</title>
		<link>http://www.tapanray.in/does-patient-centricity-now-sound-like-a-cliche/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=does-patient-centricity-now-sound-like-a-cliche</link>
		<comments>http://www.tapanray.in/does-patient-centricity-now-sound-like-a-cliche/#comments</comments>
		<pubDate>Mon, 11 Feb 2019 00:00:22 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[care]]></category>
		<category><![CDATA[centricity]]></category>
		<category><![CDATA[Cliché]]></category>
		<category><![CDATA[Consumerism]]></category>
		<category><![CDATA[corporate]]></category>
		<category><![CDATA[cultural]]></category>
		<category><![CDATA[dichotomy]]></category>
		<category><![CDATA[disparity]]></category>
		<category><![CDATA[fundamental]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[mindset]]></category>
		<category><![CDATA[Patient]]></category>
		<category><![CDATA[Patients]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[shift]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=9405</guid>
		<description><![CDATA[Today, many pharma companies claim ‘patient-centricity’ as one of their primary focus areas in business. Many industry experts, as well, have been advocating so, over a period of time. A number of research studies, published during the last several years, &#8230; <a href="http://www.tapanray.in/does-patient-centricity-now-sound-like-a-cliche/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/does-patient-centricity-now-sound-like-a-cliche/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Indian Pharma To Stay Ahead of The Technology Curve</title>
		<link>http://www.tapanray.in/indian-pharma-to-stay-ahead-of-the-technology-curve/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=indian-pharma-to-stay-ahead-of-the-technology-curve</link>
		<comments>http://www.tapanray.in/indian-pharma-to-stay-ahead-of-the-technology-curve/#comments</comments>
		<pubDate>Mon, 22 May 2017 00:00:23 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[Ahead]]></category>
		<category><![CDATA[AI]]></category>
		<category><![CDATA[applications]]></category>
		<category><![CDATA[Artificial]]></category>
		<category><![CDATA[Change]]></category>
		<category><![CDATA[Chatbot]]></category>
		<category><![CDATA[curve]]></category>
		<category><![CDATA[digital]]></category>
		<category><![CDATA[generic]]></category>
		<category><![CDATA[humanoids]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[Indian]]></category>
		<category><![CDATA[Intelligence]]></category>
		<category><![CDATA[mandatory]]></category>
		<category><![CDATA[Medical]]></category>
		<category><![CDATA[paradigm]]></category>
		<category><![CDATA[patient-centric]]></category>
		<category><![CDATA[platforms]]></category>
		<category><![CDATA[prescription]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[representatitves]]></category>
		<category><![CDATA[shift]]></category>
		<category><![CDATA[staying]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[technology]]></category>
		<category><![CDATA[tools]]></category>
		<category><![CDATA[virtual]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=8236</guid>
		<description><![CDATA[In the ever-changing business environment, many industrial sectors have now started leveraging different cutting-edge technological platforms to improve overall strategic and operational effectiveness, keeping a sharp focus on better stakeholder engagement for greater customer satisfaction. These companies have accepted the &#8230; <a href="http://www.tapanray.in/indian-pharma-to-stay-ahead-of-the-technology-curve/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/indian-pharma-to-stay-ahead-of-the-technology-curve/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Pharmaceutical Brand Building in a Changing Scenario: Thinking Outside the Box</title>
		<link>http://www.tapanray.in/pharmaceutical-brand-building-in-a-changing-scenario-thinking-outside-the-box/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=pharmaceutical-brand-building-in-a-changing-scenario-thinking-outside-the-box</link>
		<comments>http://www.tapanray.in/pharmaceutical-brand-building-in-a-changing-scenario-thinking-outside-the-box/#comments</comments>
		<pubDate>Mon, 18 Feb 2013 00:00:24 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[advair]]></category>
		<category><![CDATA[brands]]></category>
		<category><![CDATA[building]]></category>
		<category><![CDATA[changing]]></category>
		<category><![CDATA[emotional]]></category>
		<category><![CDATA[equity]]></category>
		<category><![CDATA[GSK]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[Lipitor]]></category>
		<category><![CDATA[mega]]></category>
		<category><![CDATA[nexium]]></category>
		<category><![CDATA[NovoNordisk]]></category>
		<category><![CDATA[NPPA]]></category>
		<category><![CDATA[paradigm]]></category>
		<category><![CDATA[pharmaceutical]]></category>
		<category><![CDATA[R&D]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Roche]]></category>
		<category><![CDATA[shift]]></category>
		<category><![CDATA[Tapan]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=1405</guid>
		<description><![CDATA[In this article, I shall explore unconventional ways of “Building sustainable Pharmaceutical Brands” thinking  outside the box, after quickly taking you through the “Challenges of Change” in the evolving dynamics of  the Indian branded generic market. A paradigm shift has &#8230; <a href="http://www.tapanray.in/pharmaceutical-brand-building-in-a-changing-scenario-thinking-outside-the-box/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/pharmaceutical-brand-building-in-a-changing-scenario-thinking-outside-the-box/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Envisaging a paradigm shift in strategic marketing of pharmaceutical in India</title>
		<link>http://www.tapanray.in/envisaging-a-paradigm-shift-in-strategic-marketing-of-pharmaceutical-in-india/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=envisaging-a-paradigm-shift-in-strategic-marketing-of-pharmaceutical-in-india</link>
		<comments>http://www.tapanray.in/envisaging-a-paradigm-shift-in-strategic-marketing-of-pharmaceutical-in-india/#comments</comments>
		<pubDate>Mon, 11 Oct 2010 01:00:14 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[a]]></category>
		<category><![CDATA[brand]]></category>
		<category><![CDATA[drugs]]></category>
		<category><![CDATA[Envisaging]]></category>
		<category><![CDATA[in]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[marketing]]></category>
		<category><![CDATA[Medicines]]></category>
		<category><![CDATA[of]]></category>
		<category><![CDATA[paradigm]]></category>
		<category><![CDATA[pharmaceutical]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[shift]]></category>
		<category><![CDATA[Strategic]]></category>
		<category><![CDATA[Tapan]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=363</guid>
		<description><![CDATA[PricewaterhouseCoopers (PwC) recommended, about three years ago, in mid-2007 that for sustainable business performance the research-based global pharmaceutical companies should move a part of their significant expenditure from marketing to research. They also recommended that the drug prices should be &#8230; <a href="http://www.tapanray.in/envisaging-a-paradigm-shift-in-strategic-marketing-of-pharmaceutical-in-india/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/envisaging-a-paradigm-shift-in-strategic-marketing-of-pharmaceutical-in-india/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>New Drug Policy 2009 – suggesting key elements for a strategic shift in the policy framework</title>
		<link>http://www.tapanray.in/new-drug-policy-2009-suggesting-key-elements-for-a-strategic-shift-in-the-policy-framework/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=new-drug-policy-2009-suggesting-key-elements-for-a-strategic-shift-in-the-policy-framework</link>
		<comments>http://www.tapanray.in/new-drug-policy-2009-suggesting-key-elements-for-a-strategic-shift-in-the-policy-framework/#comments</comments>
		<pubDate>Mon, 01 Jun 2009 00:30:06 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[2009]]></category>
		<category><![CDATA[a]]></category>
		<category><![CDATA[Drug]]></category>
		<category><![CDATA[elements]]></category>
		<category><![CDATA[for]]></category>
		<category><![CDATA[framework]]></category>
		<category><![CDATA[in]]></category>
		<category><![CDATA[key]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Policy]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[shift]]></category>
		<category><![CDATA[Strategic]]></category>
		<category><![CDATA[suggesting]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[the]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=872</guid>
		<description><![CDATA[The new drug policy of the Government of India (GoI) is long overdue. Despite so many reform measures taken by various Governments over last two decades, Indian Pharmaceutical Industry has not seen a new &#8216;drug policy&#8217;since 1995.As an individual who &#8230; <a href="http://www.tapanray.in/new-drug-policy-2009-suggesting-key-elements-for-a-strategic-shift-in-the-policy-framework/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/new-drug-policy-2009-suggesting-key-elements-for-a-strategic-shift-in-the-policy-framework/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
